A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors
Takeda
Takeda
Actym Therapeutics, Inc.
Sotio Biotech Inc.
Deciphera Pharmaceuticals, LLC
Pfizer
University of Maryland, Baltimore
MacroGenics
Incyte Corporation
National Institutes of Health Clinical Center (CC)